Posts tagged AEZS


AEterna Zentaris Inc. (USA) (AEZS) Stock Fires Up to the Roof; Here’s Why

AEterna Zentaris Inc. (USA)(NASDAQ:AEZS) investors are busy throwing a party today following the news that tiny …

Jason Kolbert Believes AEterna Zentaris Inc. (USA) (AEZS) Is “Deeply Undervalued;” Shares Leap 64% Following FDA Win for AGHD Drug

Maxim’s Jason Kolbert bets AEZS’ oral test could set a new standard in addressing Adult Growth Hormone Deficiency (AGHD) with FDA approval now under its belt.

AEterna Zentaris Inc. (USA) (AEZS) Investors Celebrate FDA Approval; Shares Skyrocket

Investors love biotech stocks for the lottery ticket-like returns they can offer if a company …

Ahead of Big Catalyst, AEterna Zentaris Inc. (AEZS) Announced Departure of Interim Chief Financial Officer

December is an exciting month for AEterna Zentaris Inc. (NASDAQ:AEZS) investors, with the upcoming PDUFA …

AEterna Zentaris Inc.’s (USA) (AEZS) Growth Hormone Drug Accepted for EU Review

AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) announced that the Marketing Authorization Application (MAA) for the use …

Company Update: AEterna Zentaris Inc. (AEZS) Announces 3Q:17 Highlights and Financial Results

AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) reported financial and operating results for the third quarter ended …

Jim Simons’ Take on 3 Small Cap Biotech Stocks: Kamada Ltd, AEterna Zentaris Inc. (USA), Antares Pharma Inc

Known by many as “the world’s smartest billionaire”, Jim Simons is the founder of the …

AEterna Zentaris Inc. (USA) (AEZS) Engages Advisors and Provides Update to Shareholders

AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) announced today that the special committee of independent directors (the …

AEterna Zentaris Inc. (USA) (AEZS) to Take Legal Action Against Former CEO and Former General Counsel

 AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) announced today that it has filed a claim against the Company’s …

AEterna Zentaris Inc. (USA) (AEZS) CEO’s Departure Raises Questions

AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) shares are tumbling nearly 7% in Monday’s trading session, following …

Show More